
News & Media
Newsroom
SK Biopharmaceuticals Submits Supplemental New Drug Application to U.S. FDA for Cenobamate
11.4.2026
Full Release
SK Life Science, Inc. Introduces Access+ to Simplify the Patient Support Experience
11.2.2026
Full Release
SK Life Science Supports SUDEP Awareness Efforts Through Partnership with CURE Epilepsy and The Cameron Boyce Foundation
10.14.2026
Full Release
Welcome to the news and information center for SK Life Science, Inc.
To learn more about SK Life Science, please download our corporate brochure
For more information about epilepsy, please download this infographic
To view the Hope, Hesitancy, and Hard Truths survey report, please click here.

SK Life Science at a Glance
Headquarters Location: Paramus, NJ
Parent Company: SK Life Science is a subsidiary of SK Biopharmaceuticals, Co., Ltd, and both are part of SK Group
Number of Employees: 200+ Employees
Disease Category Focus: CNS Disorders and Oncology
Pipeline: 12 compounds under clinical development
